GENE ONLINE|News &
Opinion
Blog

2023-09-11| Asia-PacificM&A

Health Innovations Acquires a Singapore-based Startup, Strengthening Digital Healthcare

by Sinead Huang
Share To

Health Innovations, a consortium of practicing medical doctors affiliated with GP+ cooperative, has announced its successful acquisition of AskDr, a prominent digital health startup based in Singapore. This strategic merger has positioned the group to make a significant impact on healthcare across the Asia Pacific region, a particularly pertinent development as Singapore transitions to a value-based care system known as “Healthier SG.”

Related article: Singapore-based Biotech Startup Announces $5.6 Million Pre-A Financing Round Led By Multiple Investors

AskDr’s Valuable Contribution

AskDr, led by founder Mr. Brian Toh and co-founder Dr. Dinesh Visva Gunasekeran, gained recognition for its innovative online health community (OHC) platform during the COVID-19 pandemic. This platform facilitated patient access to trusted medical advice and personalized health information while addressing medical misinformation and providing remote professional medical training.

AskDr achieved noteworthy revenue growth, attracting Fortune 500 customers, including AstraZeneca, GSK, and Roche. The acquisition will enable AskDr to reach a broader audience, offering accurate health information and empowering doctors to combat medical misinformation on a larger scale.

Empowering Digital Healthcare  

Health Innovations’ acquisition of AskDr, though undisclosed in sum, unites a team of highly skilled doctors, entrepreneurs, and health technology experts. Their common goal is to enhance patient care and empower individuals to actively manage their health journeys.

Dr. Gunasekeran, one of the co-founders with prior digital health experience and recognition in Forbes’ 30 under 30 list, expresses the motivation to solve patient-related problems and improve healthcare during the pandemic.

Transforming the Digital Health Landscape

The integration of AskDr’s technology and expertise with Health Innovations’ established practices is poised to reshape the digital healthcare landscape in the Asia Pacific. Dr. Gerard Lin, Director of Health Innovations, anticipates accelerating the adoption of innovative digital solutions, enabling professional training, delivering reliable patient information, and improving access to high-quality healthcare services throughout the region.

This strategic acquisition marks a significant step forward in the advancement of digital healthcare across the Asia Pacific region.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Nucleate Taiwan Bridging Academia and Industry in the Field of Synbio
2024-07-02
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
LATEST
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top